Kevin Rendino of 180 Degree Capital joins the podcast to discuss reasons for optimism (yes, optimism) in markets and why we may have already reached “peak pain.”
Corona virus, COVID 19
Edward Olanow, portfolio manager and director of investment solutions at Weiss Multi-Strategy Advisers, joins the podcast to supply a surprisingly bullish outlook on the economy and on certain segments of the stock market.
- Reasons for optimism: Given the Fed and external shocks, GDP remains high and there is still a backlog of orders and millions of unfilled jobs (3:15);
- The Fed’s talk about 0.75% interest rate hikes is “just jawboning” (5:33);
- The era of ‘buy & hold’ is over; investors need to be more nimble (8:25);
- The house view at Weiss is that Nasdaq stocks will have a tougher time than other segments of the market (10:40);
- The war in Ukraine: in all likelihood risks are localized at present, judging by gold and energy prices (14:25);
- Background on the guest (18:40);
- What are dispersion trades and how do they work? (20:34);
- Why this may be a good time for this strategy — and a ‘turning point’ for alternatives managers in general (26:27);
- Where all this leaves fixed income and the bond market: Fixed-income is less forward-looking than people think… (29:55);
- What Olanow and Weiss monitor for inflation (32:31);
For More Information:
Allen Bond, managing director and portfolio manager at Jensen Investment Management in Lake Oswego, Ore., joins the podcast to provide some stock picks for an increasingly uncertain — and inflationary — time in global financial markets.
- Investors have two major issues they’re grappling with right now: Ukraine and inflation (5:51);
To protect against inflationary pressures, Jensen looks for businesses that have pricing power (11:11);
- Mastercard (MA) and TJX (TJX) are two such stocks (13:29);
Background on the guest (19:36);
- Three additional stock ideas, starting with ADP (ADP), another company that is difficult to displace (28:54);
Broadridge Financial Solutions (BR), the leading provider of proxy services (35:51);
Pfizer (PFE) has sold off since making Covid vaccine headlines last year, but continues to generate a ton of cash — and put it to productive use (43:26).